The immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: Study protocol for a randomised clinical trial

• Main Authors: Young, B, Sadarangani, S, Yew, H.S, Yung, C.F, Leo, Y.S, Chen, M.-C, Wilder-Smith, A
• Other Authors: SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
• Format: Article
• Published: 2020
• Subjects: diphtheria pertussis tetanus vaccine; hemagglutination inhibiting antibody; influenza vaccine; virus antibody; aged; antibody titer; Article; cellular immunity; clinical protocol; controlled study; dosage schedule comparison; drug effect; drug safety; human; immune response; infection prevention; influenza; influenza vaccination; Influenza virus; major clinical study; medication compliance; nonhuman; parallel design; patient compliance; phase 4 clinical trial; randomized controlled trial; risk assessment; Singapore; virus neutralization; virus strain; age; blood; clinical trial; comparative study; drug effects; female; hemagglutination inhibition test; immunization; immunology; male; methodology; time factor; treatment outcome; vaccination; vaccine immunogenicity; virology; Age Factors; Aged; Antibodies, Viral; Clinical Protocols; Female; Hemagglutination Inhibition Tests; Humans; Immunity, Cellular; Immunization Schedule; Immunogenicity, Vaccine; Influenza Vaccines; Influenza, Human; Male; Research Design; Time Factors; Treatment Outcome; Vaccination
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/179527
• Institution: National University of Singapore

10.1186/s13063-017-1808-8